News search

    E.g., 16/11/2025
    E.g., 16/11/2025
    Dr. Valentín Fuster, Dr. Xavier Rosselló y Dr. Borja Ibáñez.
    Research
    9 Nov 2025
    NEJM: Major international study confirms that beta-blockers are no longer needed in post-infarction patients with normal heart function

    The study, published in The New England Journal of Medicine, shows that beta-blockers do not reduce mortality, recurrent infarction, or heart failure in post-infarction patients with normal cardiac function
    CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
    Research
    30 Aug 2025
    NEJM & The Lancet: CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

    REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the heart intact.
    ESC Congress 2025
    About the CNIC
    30 Aug 2025
    EHJ: New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

    The REBOOT study was presented during the European Society of Cardiology Congress (ESC Congress 2025) in Madrid
    ESC Congress 2025 CNIC
    About the CNIC
    26 Aug 2025
    The CNIC at the European Cardiology Congress 2025

    The European Society of Cardiology is holding its annual congress in Madrid from August 29 to September 1
    About the CNIC
    6 Aug 2021
    RREBOOT, on a mission to change clinical practice guidelines for the treatment of heart attack survivors

    CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction